NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Earnings & Estimates
Europe - FRA:NZM2 - DK0060336014 - Common Stock
52.48 EUR
+1.12 (+2.18%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.352B 17.30% | 2.398B 1.97% | 3.834B 59.85% | 4.217B 10.00% | 4.501B 6.73% | 4.815B 6.98% | 5.221B 8.43% | 5.55B 6.30% | 5.901B 6.32% | 6.194B 4.97% | 6.519B 5.25% | |
| EBITDA YoY % growth | 795.995M 11.09% | 784.204M -1.48% | 1.256B 60.21% | 1.571B 25.04% | 1.725B 9.80% | 1.868B 8.29% | 2.05B 9.74% | 2.179B 6.29% | 2.337B 7.25% | 2.424B 3.72% | 2.554B 5.36% | |
| EBIT YoY % growth | 597.03M 13.37% | 598.101M 0.18% | 659M 10.18% | 1.063B 61.31% | 1.197B 12.61% | 1.324B 10.61% | 1.501B 13.37% | 1.623B 8.13% | 1.762B 8.56% | 1.684B -4.43% | 1.79B 6.29% | |
| Operating Margin | 25.39% | 24.94% | 17.19% | 25.21% | 26.59% | 27.50% | 28.75% | 29.24% | 29.86% | 27.19% | 27.46% | |
| EPS YoY % growth | 13.20 17.54% | 3.90 -70.44% | N/A -66.52% | 1.84 41.09% | 2.04 10.43% | 2.24 9.92% | 2.58 15.41% | 2.81 8.78% | 3.04 8.28% | 3.16 3.83% | 3.34 5.75% |
All data in EUR
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.37 2.51% | 0.83 130.45% |
| Revenue Q2Q % growth | 1.079B 6.94% | 1.054B -47.35% |
| EBITDA Q2Q % growth | 413.09M | 391.88M -47.95% |
| EBIT Q2Q % growth | N/A | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.47 45.88% | 0.41 | 0.06 | 14.06% |
| Q1 2025 Q2Q % growth | 0.42 30.36% | 0.39 | 0.03 | 6.35% |
| Q4 2024 Q2Q % growth | 7.40% | 0.36 | % | |
| Q3 2024 Q2Q % growth | -20.06% | 0.36 | % | |
| Q2 2024 Q2Q % growth | 10.07% | 0.32 | % | |
| Q1 2024 Q2Q % growth | -88.57% | 0.32 | % | |
| Q4 2023 Q2Q % growth | 0.34 -89.41% | 0.39 | -0.06 | -14.49% |
| Q3 2023 Q2Q % growth | 0.45 -89.07% | 0.38 | 0.08 | 20.08% |
| Q2 2023 Q2Q % growth | 0.29 -89.91% | 0.37 | -0.07 | -19.98% |
| Q1 2023 Q2Q % growth | 2.82 -5.37% | 2.85 | -0.03 | -1.12% |
| Q4 2022 Q2Q % growth | 3.18 41.96% | 2.74 | 0.44 | 15.87% |
| Q3 2022 Q2Q % growth | 4.14 37.54% | 3.91 | 0.23 | 5.85% |
| Q2 2022 Q2Q % growth | 2.90 2.47% | 2.78 | 0.12 | 4.48% |
| Q1 2022 Q2Q % growth | 2.98 -5.40% | 3.00 | -0.02 | -0.80% |
| Q4 2021 Q2Q % growth | 2.24 -3.86% | 2.31 | -0.07 | -2.88% |
| Q3 2021 Q2Q % growth | 3.01 18.97% | 2.53 | 0.48 | 19.00% |
| Q2 2021 Q2Q % growth | 2.83 24.12% | 2.55 | 0.28 | 10.88% |
| Q1 2021 Q2Q % growth | 3.15 9.38% | 2.52 | 0.63 | 25.12% |
| Q4 2020 Q2Q % growth | 2.33 -28.31% | 2.51 | -0.18 | -7.14% |
| Q3 2020 Q2Q % growth | 2.53 13.45% | 2.42 | 0.11 | 4.50% |
| Q2 2020 Q2Q % growth | 2.28 -26.92% | 2.32 | -0.04 | -1.59% |
| Q1 2020 Q2Q % growth | 2.88 19.50% | 2.86 | 0.02 | 0.70% |
| Q4 2019 Q2Q % growth | 3.25 | 2.86 | 0.39 | 13.75% |
| Q3 2019 Q2Q % growth | 2.23 | 2.56 | -0.33 | -12.94% |
| Q2 2019 Q2Q % growth | 3.12 | 3.20 | -0.08 | -2.42% |
| Q1 2019 Q2Q % growth | 2.41 | 2.74 | -0.33 | -12.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.019B -44.40% | 1.042B | -23.5M | -2.26% |
| Q1 2025 Q2Q % growth | 1.078B 10.50% | 1.074B | 3.6M | 0.34% |
| Q4 2024 Q2Q % growth | 2.002B 224.28% | 1.002B | 1B | 99.78% |
| Q3 2024 Q2Q % growth | 68.85% | 1.009B | % | |
| Q2 2024 Q2Q % growth | 1.832B -56.56% | 980.17M | 851.53M | 86.88% |
| Q1 2024 Q2Q % growth | -78.91% | 975.22M | % | |
| Q4 2023 Q2Q % growth | 617.312M -86.37% | 625.01M | -7.698M | -1.23% |
| Q3 2023 Q2Q % growth | 597.574M -86.32% | 596.24M | 1.334M | 0.22% |
| Q2 2023 Q2Q % growth | 4.217B -1.61% | 593.32M | 3.624B | 610.75% |
| Q1 2023 Q2Q % growth | 4.623B 5.77% | 4.581B | 42M | 0.92% |
| Q4 2022 Q2Q % growth | 4.529B 18.13% | 4.571B | -42M | -0.92% |
| Q3 2022 Q2Q % growth | 4.367B 16.11% | 4.437B | -70M | -1.58% |
| Q2 2022 Q2Q % growth | 4.286B 19.72% | 4.091B | 195M | 4.77% |
| Q1 2022 Q2Q % growth | 4.371B 15.76% | 4.226B | 145M | 3.43% |
| Q4 2021 Q2Q % growth | 3.834B 11.26% | 3.782B | 52M | 1.37% |
| Q3 2021 Q2Q % growth | 3.761B 9.62% | 3.719B | 42M | 1.13% |
| Q2 2021 Q2Q % growth | 3.58B 6.90% | 3.557B | 23M | 0.65% |
| Q1 2021 Q2Q % growth | 3.776B -0.26% | 3.555B | 221M | 6.22% |
| Q4 2020 Q2Q % growth | 3.446B -7.64% | 3.578B | -132M | -3.69% |
| Q3 2020 Q2Q % growth | 3.431B -7.37% | 3.521B | -90M | -2.56% |
| Q2 2020 Q2Q % growth | 3.349B -3.15% | 3.374B | -25M | -0.74% |
| Q1 2020 Q2Q % growth | 3.786B 8.76% | 3.776B | 10M | 0.26% |
| Q4 2019 Q2Q % growth | 3.731B | 3.779B | -48M | -1.27% |
| Q3 2019 Q2Q % growth | 3.704B | 3.823B | -119M | -3.11% |
| Q2 2019 Q2Q % growth | 3.458B | 3.64B | -182M | -5.00% |
| Q1 2019 Q2Q % growth | 3.481B | 3.656B | -175M | -4.79% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.39% | N/A | 0% | N/A |
| Revenue | 0% | N/A | -0.17% | N/A |